FDA Inspection
Aspire Houston Fertility InstituteAspire Houston Fertility Institute – FDA Inspection, Nov 1, 2010
Record Details
This FDA Inspection record concerns Aspire Houston Fertility Institute, with an inspection on November 1, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- November 1, 2010
- Product Type
- Biologics
View Company Profile
ID · 0aba8172-3c99-418a-9a84-f75aa697a531
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 695932
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.47(a)Procedures for all other requirements
- 21 CFR 1271.55(b)(1)Statement re: certified testing lab
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aspire Houston Fertility Institute
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 6, 2020 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 24, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 19, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Aspire Houston Fertility Institute
- FDA Inspection 1249226 - 2024-08-28
- FDA Inspection 1117002 - 2020-02-06
- FDA Inspection 1041022 - 2018-01-24
- FDA Inspection 1014004 - 2016-12-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.